Literature DB >> 11341130

Lessons from cisapride.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11341130      PMCID： PMC80999     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Drug interactions: Who warns the patient.

Authors: 
Journal:  CMAJ       Date:  1999-07-27       Impact factor: 8.262

2.  Cisapride and patient information leaflets.

Authors:  S R Sukkari; L D Sasich
Journal:  CMAJ       Date:  2001-05-01       Impact factor: 8.262

3.  Contraindicated use of cisapride: impact of food and drug administration regulatory action.

Authors:  W Smalley; D Shatin; D K Wysowski; J Gurwitz; S E Andrade; M Goodman; K A Chan; R Platt; S D Schech; W A Ray
Journal:  JAMA       Date:  2000-12-20       Impact factor: 56.272
  3 in total
  4 in total

1.  Cisapride and the Vanessa Young inquest.

Authors:  W Arnott
Journal:  CMAJ       Date:  2001-08-21       Impact factor: 8.262

2.  We need Romanow's National Drug Agency.

Authors: 
Journal:  CMAJ       Date:  2003-02-04       Impact factor: 8.262

3.  Editorial autonomy of CMAJ.

Authors:  Jerome P Kassirer; Frank Davidoff; Kathryn O'Hara; Donald A Redelmeier
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

Review 4.  Dealing with global safety issues : was the response to QT-liability of non-cardiac drugs well coordinated?

Authors:  Norman Stockbridge; Joel Morganroth; Rashmi R Shah; Christine Garnett
Journal:  Drug Saf       Date:  2013-03       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.